Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

+ Add to Watchlist

VEFV:GR

65.9800 EUR 1.0200 1.52%

As of 13:37:17 ET on 04/27/2015.

Snapshot for Market Vectors Pharmaceutical ETF (VEFV)

Open: 66.8500 High - Low: 67.0600 - 65.9300 Primary Exchange: Berlin
Volume: 0 52-Week Range: 42.4600 - 68.5700 Beta vs MVPPHTR: 0.9822

ETF Chart for VEFV

No chart data available.
  • VEFV:GR 65.9800
  • 1D
  • 1M
  • 1Y
67.0000
Interactive VEFV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VEFV

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2009-03-20 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for VEFV

NAV -
Assets (M) (on 2015-04-24) 387.3878
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for VEFV

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-04-01) 0.4975
Dividend Yield (ttm) 1.52%

Performance for VEFV

1-Month +3.07% 1-Year +59.19%
3-Month +13.80% 3-Year +37.15%
Year To Date +26.42% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for VEFV

Filing Date: 04/24/2015
Name Position Value % of Total
Novartis AG 353,086 36,819,808 9.497%
Johnson & Johnson 316,962 32,038,519 8.264%
Pfizer Inc 740,742 26,125,970 6.739%
Novo Nordisk A/S 391,411 22,173,433 5.719%
Sanofi 383,734 19,858,235 5.122%
AbbVie Inc 286,253 18,912,736 4.878%
Merck & Co Inc 321,233 18,503,021 4.773%
GlaxoSmithKline PLC 394,661 18,387,256 4.743%
Actavis plc 61,488 18,164,170 4.685%
AstraZeneca PLC 251,513 18,056,118 4.657%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil